Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 5/20 | 0.73 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.73 |
| ▸ | HPGD | P15428 | 5/20 | 0.73 |
| ▸ | TSHR | P16473 | 4/20 | 0.73 |
| ▸ | MAPT | P10636 | 4/20 | 0.73 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.73 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.73 |
| ▸ | LMNA | P02545 | 2/20 | 0.73 |
| ▸ | RGS12 | O14924 | 1/20 | 0.73 |
| ▸ | POLB | P06746 | 1/20 | 0.73 |
| ▸ | APEX1 | P27695 | 1/20 | 0.73 |
| ▸ | THPO | P40225 | 1/20 | 0.73 |
| ▸ | BLM | P54132 | 1/20 | 0.73 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.73 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.73 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.73 |
| ▸ | CA2 | P00918 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11288680 | 0.87 | GAA (0.61) | GAAKDM4EHPGDTSHRMAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL29382155 | 0.84 | GAA (1.00) | GAAKDM4EHPGDTSHRMAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL36348 | 0.84 | GAA (1.00) | GAAKDM4EHPGDTSHRMAPT | |
| SCHEMBL14768434 | 0.83 | KDM4E (0.53) | GAAKDM4EHPGDTSHRMAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214147 | 0.83 | GAA (0.96) | GAAKDM4EHPGDTSHRMAPT | |
| 3,4-Dihydroxyphenylacetic Acid SCHEMBL8214151 | 0.83 | GAA (0.96) | GAAKDM4EHPGDTSHRMAPT | |
| SCHEMBL30712036 | 0.81 | GAA (0.70) | GAAKDM4EHPGDTSHRMAPT | |
| SCHEMBL14764387 | 0.81 | GAA (0.70) | GAAKDM4EHPGDTSHRMAPT | |
| SCHEMBL10825727 | 0.81 | GAA (0.70) | GAAKDM4EHPGDTSHRMAPT | |
| SCHEMBL9634006 | 0.79 | CNR1 (0.57) | GAAKDM4EHPGDTSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116559134-A | On-line monitoring method and device for gaseous peroxide content | 北京大学 | 2023-08-08 | — | — | CN | claimed |
| CN-116559133-A | On-line monitoring method and device for gaseous peroxide content in ambient air | 北京大学 | 2023-08-08 | — | — | CN | claimed |
| EP-1706402-A4 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA LTD (CA) | 2009-03-18 | — | — | EP | claimed |
| EP-1706402-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | Merck Frosst Canada Ltd. (CA) | 2006-10-04 | — | — | EP | claimed |
| WO-2005066159-A1 | CATHEPSIN CYSTEINE PROTEASE INHIBITORS | MERCK FROSST CANADA LTD. (CA) | 2005-07-21 | — | — | WO | claimed |
| CN-116559134-A | On-line monitoring method and device for gaseous peroxide content | 北京大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-116559133-A | On-line monitoring method and device for gaseous peroxide content in ambient air | 北京大学 | 2023-08-08 | — | — | CN | disclosed |
| CN-217820006-U | A mixed structure for atmospheric peroxide automatic monitoring system | 中国环境科学研究院 | 2022-11-15 | — | — | CN | disclosed |
| CN-217795847-U | A mixed structure for automatic continuous monitoring system of atmosphere peroxide | 中国环境科学研究院 | 2022-11-15 | — | — | CN | disclosed |
| US-8227510-B2 | Combine use of pterostilbene and quercetin for the production of cancer treatment medicaments | UNIVERSITAT DE VALENCIA (ES) | 2012-07-24 | — | — | US | disclosed |
| US-20110224290-A1 | COMBINE USE OF PTEROSTILBENE AND QUERCETIN FOR THE PRODUCTION OF CANCER TREATMENT MEDICAMENTS | WESTERN ALLIANCE BANK | 2011-09-15 | — | — | US | disclosed |
| US-20110136751-A1 | Use of Polyphenols in the Treatment of Cancer | GREEN MOLECULAR (ES) | 2011-06-09 | — | — | US | disclosed |
| US-5306618-A | Using xanthene dye reporter labeled DNA fragments | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1994-04-26 | — | — | US | disclosed |
| US-5242796-A | Fluorescent xanthene dye | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-09-07 | — | — | US | disclosed |
| EP-0185547-B1 | POLYNUCLEOTIDE HYBRIDIZATION ASSAYS EMPLOYING CATALYZED LUMINESCENCE | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-06-03 | — | — | EP | disclosed |
| US-5102785-A | Cleaving to produce DNA fragment which are then end labeled with reporter, again cleaved to produce short fragment, separatiion; analysis | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-07 | — | — | US | disclosed |
| US-4983511-A | Method and kit for detecting live microorganisms in chlorine- or bromine-treated water | OLIN CORPORATION (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0309969-A2 | Method of gene mapping | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-04-05 | — | — | EP | disclosed |
| US-4670379-A | Polynucleotide hydridization assays employing catalyzed luminescence | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-06-02 | — | — | US | disclosed |
| EP-0185547-A2 | Polynucleotide hybridization assays employing catalyzed luminescence | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1986-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110136751-A1 | Use of Polyphenols in the Treatment of Cancer | TP53, PGC, VHL | GAA 849/4885KDM4E 1570/4885HPGD 200/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.